Argininosuccinate Lyase Drives Activation of Mutant TERT Promoter in Glioblastomas

Zhumei Shi,Xin Ge,Mengdie Li,Jianxing Yin,Xiefeng Wang,Junxia Zhang,Dongyin Chen,Xinjian Li,Xiuxing Wang,Jing Ji,Yongping You,Xu Qian

DOI: https://doi.org/10.1016/j.molcel.2022.09.024

IF: 16

2022-01-01

Molecular Cell

Abstract:Cancer-specific TERT promoter mutations have been linked to the reactivation of epigenetically silenced TERT gene by creating de novo binding motifs for E-Twenty-Six transcription factors, especially GABPA. How these mutations switch on TERT from epigenetically repressed states to expressed states have not been defined. Here, we revealed that EGFR activation induces ERK1/2-dependent phosphorylation of argininosuccinate lyase (ASL) at Ser417 (S417), leading to interactions between ASL and GABPA at the mutant regions of TERT promoters. The ASL-generated fumarate inhibits KDM5C, leading to enhanced trimethylation of histone H3 Lys4 (H3K4me3), which in turn promotes the recruitment of c-Myc to TERT promoters for TERT expression. Expression of ASL S417A, which abrogates its binding with GABPA, results in reduced TERT expression, inhibited telomerase activity, shortened telomere length, and impaired brain tumor growth in mice. This study reveals an unrecognized mechanistic insight into epigenetically activation of mutant TERT promoters where GABPA-interacted ASL plays an instrumental role.